Norges Bank Investment Management has agreed to buy a 45% stake in a 810,000 sq ft life sciences development in Cambridge, Massachusetts, from New York-listed BXP. The Norwegian investor has paid $746.7m (£600m) for the stake in Kendall Square, valuing
Thank you for reading EG
Want to read more? Enjoy a story a day for FREE for one month.
Register
Find Out More